Motilal Oswal Recommends BUY on PPL Pharma with Target Price of Rs 260

Posted on 30/09/2024 by bigbreakingwire

Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.

bigbreakingwire

Stay informed with our financial updates, stocks, bonds, commodities. Get global & political insights. Follow us & enable notifications for the latest updates.

bigbreakingwire.in

Moody’s Adjusts Outlook to Negative for Banking Sectors in Germany, Britain, France, Belgium, the Netherlands, and Sweden

bigbreakingwire
07/03/2024
0

On Thursday, credit rating agency Moody’s announced a shift in its outlook for the banking sectors in several European countries. The outlook for Germany, Britain, […]

EU Readies Probe into Meta’s Facebook and Instagram Over Disinformation Concerns

bigbreakingwire
29/04/2024
0

The European Union in Brussels is poised to initiate an investigation into Meta’s Facebook and Instagram platforms, possibly commencing as early as Monday. This move […]

ESG Fund Managers Raise Alarms on Nvidia: Evaluating Concerns Amidst Potential Stock Bubble

bigbreakingwire
07/03/2024
3

ESG fund managers, who previously benefited from Nvidia Corp (NVDA), are worried that there might be a bubble in the company’s stock. Bloomberg reports a […]